---
title: PI Health Sciences vs Syngene International
slug_a: pihealthsciences
slug_b: syngeneintl
site: cdmo
review_signal_gate: closed
canonical_path: /compare/pihealthsciences/syngeneintl
---

# PI Health Sciences vs Syngene International

Side-by-side profile data from each company listing on this directory.

## PI Health Sciences

- Profile: [/companies/pihealthsciences](/companies/pihealthsciences)

PI Health Sciences — PI Health Sciences is an integrated CRDMO offering end-to-end drug discovery, development, and manufacturing services with R&D and manufacturing locations in Europe and India.

Services: 28. Modalities: 1. Indications: 0. Locations: 10. Certifications: 0. The strongest documented coverage currently appears in services (28).

### Services

- Discovery Research
- Target Identification & Validation
- High-Throughput Screening
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- Genetic Toxicology
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- GLP Toxicology
- Regulatory Affairs
- Analytical Method Development & Validation
- ICH Stability Studies
- Translational Research
- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Flow Chemistry & Continuous Manufacturing
- Solid-State Chemistry & Polymorph Screening
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development
- ICH stability testing
- Solid-state characterization

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- HPAPI
- Flow Chemistry

## Syngene International

- Profile: [/companies/syngeneintl](/companies/syngeneintl)

Syngene International — Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.

Services: 100. Modalities: 10. Indications: 14. Locations: 3. Certifications: 0. The strongest documented coverage currently appears in services (100).

### Services

- Discovery Research
- Medicinal Chemistry
- Computational & In-Silico Drug Discovery
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- GLP Toxicology
- Analytical Method Development & Validation
- Formulation Development
- Process Development
- CMC Analytical Development
- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Vial Filling
- Prefilled Syringe (PFS) Filling
- Cell-Line Development
- Recombinant Protein Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Biologics Development & Manufacturing
- Upstream Processing
- Downstream Processing
- Bioanalysis
- Peptide Manufacturing
- Oligonucleotide Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- Cell Therapy Manufacturing
- mRNA Manufacturing
- Translational Research
- High-Throughput Screening
- Genetic Toxicology
- Preclinical In Vitro Studies
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- Carcinogenicity Studies
- DART (Reproductive & Developmental Toxicology)
- Specialized & Large-Animal Models
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Flow Cytometry Services
- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Central Laboratory Services
- Clinical Imaging Core Lab
- Regulatory Affairs
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Japan PMDA Regulatory Strategy
- China NMPA Regulatory Strategy
- ICH Stability Studies
- Companion Diagnostics Development
- Microbiology Services
- Virology Services
- Immunology & Inflammation Services
- Oncology Specialty Services
- CNS Specialty Services
- Cardiovascular & Metabolic Specialty Services
- Pathology & Histology Services
- Genomics & Sequencing Services
- Proteomics Services
- Bioinformatics & Data Science
- Device & Combination Product Services
- HPAPI Manufacturing (High-Potency)
- Controlled Substance Manufacturing
- Flow Chemistry & Continuous Manufacturing
- Solid-State Chemistry & Polymorph Screening
- Microbial Fermentation
- ADC Payload & Linker Synthesis
- Bioconjugation Services
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Lipid Nanoparticle (LNP) Formulation
- Vaccine Manufacturing
- Microbiome / Live Biotherapeutic Manufacturing
- Cartridge Filling
- Lyophilization (Freeze Drying)
- Oral Solid Dosage Manufacturing
- Topical & Semi-Solid Manufacturing
- Inhalation & Nasal Dosage Manufacturing
- Ophthalmic Manufacturing
- Technology Transfer
- Quality Control Testing
- Stability Testing & Storage
- Extractables & Leachables Studies
- Secondary Packaging & Labeling
- Serialization & Track-and-Trace

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Antibody-Drug Conjugate (ADC)
- Oligonucleotide
- mRNA
- Cell Therapy
- Gene Therapy
- Peptide
- Vaccine

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Liquid Vials
- Prefilled Syringes (PFS)
- Lyophilized Vials
- Cartridges
- Oral Solid Dose (OSD)
- Max bioreactor: Large commercial (≤10,000 L)
- Expression: Mammalian
- Expression: Microbial
- Single-Use / Disposable
- Flow Chemistry